• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: TERUMO CARDIOVASCULAR SYSTEMS CORP. TERUMO CDI 500 BLOOD PARAMETER MONITOR

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

TERUMO CARDIOVASCULAR SYSTEMS CORP. TERUMO CDI 500 BLOOD PARAMETER MONITOR Back to Search Results
Model Number 500AHCT
Device Problem Incorrect Or Inadequate Test Results (2456)
Patient Problem No Consequences Or Impact To Patient (2199)
Event Date 04/21/2015
Event Type  malfunction  
Event Description
It was reported that during use of the device for a cardiopulmonary bypass (cpb) procedure, the saturated venous oxygen (svo2) reading was 10-15 points lower than expected with the blood parameter monitor (bpm).The device was not changed out, as they recalibrated the unit.The surgical procedure was completed successfully.There was no delay, no blood loss, nor adverse consequences to the pt.Per the clinical review on 04/23/2015: the perfusionist (ccp) admitted that since the 1.69 software upgrade of this monitor, the svo2 measure is less than previously seen with the previous software version (1.65) and lower than their laboratory analyzer (especially prior to the 1st in-vivo calibration).Prior to the first in-vivo calibration (in the first 15-20 minutes of cpb), the svo2 measure of the bpm is consistently 10-15% points less than their independent laboratory analyzer.This means that in the early minutes of cpb, the bpm svo2 level is generally in the 55-60% range, while the laboratory analyzed svo2 is in the 65-75% range.According to the ccp, the bpm lower svo2 values were doubted in the early minutes of cpb as the color of the blood was brighter (red) than what the bpm svo2 values indicated.The ccp stated that prior to the 1.69 upgrade, the svo2 measures of the bpm and the laboratory analyzer were close in measurement.The ccp stated that after the in-vivo calibration, the svo2 would more closely match in some cases but in others the difference would remain 5-10% (with the bpm also being lower than the laboratory analyzed value).According to the ccp, accuracy of the other parameters measured with the hematocrit saturation module (h/sat) probe (hemoglobin [hgb] and hematocrit [hct] and the arterial shunt measurements (with bpm) have not been an issue with the 1.69 upgrade.Due to this issue, additional venous samples (more than with 1.65 software) are drawn.Since the other measured values of the bpm have been reasonable, the bpm has not been changed out during the procedures.Cases have been completed successfully, without delay and without associated blood loss.There has been no harm observed.
 
Manufacturer Narrative
Evaluation is in progress, but not yet concluded.
 
Manufacturer Narrative
(b)(4).
 
Manufacturer Narrative
The reported complaint was not confirmed.The blood parameter monitor (bpm) was returned to the manufacturer for evaluation and was found to meet specifications.In the product surveillance lab, no errors or failures were observed.Blood loop testing was performed for oxygen saturation (so2) inaccuracies on both the 1/2" and 1/4" cuvette sizes.The monitor met specifications with no inaccuracies observed during blood loop testing.If additional information becomes available on this complaint that would alter the facts and/or conclusion, a supplemental report will be filed accordingly.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
TERUMO CDI 500 BLOOD PARAMETER MONITOR
Type of Device
CDI 500
Manufacturer (Section D)
TERUMO CARDIOVASCULAR SYSTEMS CORP.
ann arbor MI 48103
Manufacturer Contact
jan winder
6200 jackson rd.
ann arbor, MI 48103
7346634145
MDR Report Key4777981
MDR Text Key5779695
Report Number1828100-2015-00393
Device Sequence Number1
Product Code DRY
Combination Product (y/n)N
Reporter Country CodeUS
PMA/PMN Number
K972962
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Health Professional,User Facility,health professional,use
Reporter Occupation Other Health Care Professional
Remedial Action Recall
Type of Report Initial,Followup,Followup,Followup
Report Date 12/11/2015
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Model Number500AHCT
Device Catalogue Number500AHCT
Was Device Available for Evaluation? Device Returned to Manufacturer
Date Returned to Manufacturer06/16/2015
Is the Reporter a Health Professional? Yes
Initial Date Manufacturer Received 04/21/2015
Initial Date FDA Received05/14/2015
Supplement Dates Manufacturer ReceivedNot provided
Not provided
Not provided
Supplement Dates FDA Received07/09/2015
08/14/2015
12/11/2015
Was Device Evaluated by Manufacturer? Yes
Date Device Manufactured07/01/2012
Is the Device Single Use? No
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Reuse
Removal/Correction Number1828100-08/07/15-002-C
Patient Sequence Number1
-
-